MedPath

Comparison of Double-kissing Crush and Double-kissing Culotte Stenting

Completed
Conditions
Coronary Artery Disease
Interventions
Procedure: double kissing crush stenting
Procedure: double kissing culotte stenting
Registration Number
NCT04789161
Lead Sponsor
Istanbul Mehmet Akif Ersoy Educational and Training Hospital
Brief Summary

True bifurcation lesions (TBLs) are not rare clinical conditions and may be associated with adverse cardiovascular outcomes due to their complex anatomy and the variety of interventional therapy. Although the provisional stenting is still effective in suitable lesions, double stent techniques can be required in selected patients. In previous studies, double kissing crush (DK-crush) stenting was revealed as superior to provisional stenting in TBL of left main coronary artery. Additionally, in recent studies, double kissing approach facilitates and highlights double kissing culotte (DK-culotte) stenting with lower stent malapposition compared to DK-crush stenting. However, to the best of our knowledge, there is no study about comparing DK-crush and DK-culotte stenting in TBLs. Our aim in this study is to compare DK-crush and DK-culotte stenting in patients with TBL.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients with de novo true bifurcation lesion (Medina classification 1,1,1 or 0,1,1 or 1,0,1)
  • The main vessel diameter is least 2.5 mm and the side branch diameter is at least 2.25 mm
Exclusion Criteria
  • Patients presenting with ST segment elevation myocardial infarction, cardiogenic shock and Killip class III-IV heart failure
  • Patients with a history of coronary artery bypass grafting surgery
  • Patients with a chronic total occlusion in the bifurcation area
  • Lesions with severe calcification that needs additional intervention such as atherectomy
  • Patients who are not suitable to use long term dual antiplatelet therapy and patients not participating in clinical follow-up
  • Patients with hematological disorders, malignancy, end stage renal (GFR<30 ml/min) and hepatic failure
  • Patients with active bleeding
  • Pregnant women
  • Patients with life-expectancy < 1 year

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
double kissing crush stentingdouble kissing crush stentingpatients with true bifurcation lesion undergoing double kissing crush stenting
double kissing culotte stentingdouble kissing culotte stentingpatients with true bifurcation lesion undergoing double kissing culotte stenting
Primary Outcome Measures
NameTimeMethod
MACE (major adverse cardiovascular events)12 months

target vessel revascularization, myocardial infarction and cardiac death

Secondary Outcome Measures
NameTimeMethod
target lesion failure24, 36 months

myocardial infarction, cardiac death

MACCEs (major adverse cerebral and cardiovascular events)12, 24, 36 months

all cause death, myocardial infarction, target lesion revascularization, target lesion revascularization, in-stent thrombosis and/or restenosis, stroke

Trial Locations

Locations (1)

Istanbul Mehmet Akif Ersoy Training and Research Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath